[Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
Different forms of protection for inventions in the pharmaceutical industry point to strategies for the perpetuation of patent protection. Based on a literature review showing the specificities of patenting in the industry, the article provides a brief history of drug patents in Brazil, a discussion of patentable and non-patentable inventions, and the modalities and traits of patent protection that aim to extend the temporary monopoly granted under the patent. Such strategies include patents targeting polimorphs and optical isomers of drugs and drug combinations and specific clinical preparations, increasingly present in the drug patent claims filed by pharmaceutical companies. The study's objective is to discuss the specificities of drug patent claims in order to help develop expertise in the area and discuss the impact of expanding the scope of patent protection. In conclusion, while the tendency to expand towards more a permissive protective scope could produce opportunities for Brazilian national inventors, it could also be harmful to a policy for access to medicines.
Instituto Nacional de Tecnologia, Avenida Venezuela 82, Rio de Janeiro, Brazil. ahaydee@int.gov.br
Anna Haydée Lanzillotti
AH
Jannuzzi
Alexandre Guimarães
AG
Vasconcellos
Cristina Gomes
CG
de Souza
D000818:Animals; D001709:Biotechnology / Q000331:legislation & jurisprudence; D001938:Brazil; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004465:Economic Competition; D006801:Humans; D018973:Intellectual Property; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence* / Q000706:statistics & numerical data; D011640:Public Policy